More than 600 school children and teachers in Greater Manchester have taken part in a new voluntary coronavirus study, which is assessing the prevalence of COVID-19 in school pupils and teachers.
Our first patient has taken part in a new clinical trial investigating potential treatments for COVID-19, as part of a nationwide research effort to meet the challenge of coronavirus.
Our first adult patient has received transfusion of blood plasma from a donor who has recovered from coronavirus (COVID-19), as part of a clinical trial looking at potential treatments for the virus.
Our first patient has taken part in an interventional research trial testing potential treatments for people with severe COVID-19 infection, being cared for in an Intensive Care Unit.
Our first patient has taken part in a research trial testing whether SNG001 – a drug treatment administered via a nebuliser – could be a potential treatment for COVID-19 (coronavirus).